• Kelowna 1 facility on track to complete total of 20 grow rooms by end of Q3 2019
• Canada-wide shortage of premium adult-use cannabis products underscores need for immediate expansion
• Multiyear deal to supply medical cannabis for Shoppers Drug Mart will provide Canadian patients with highest quality medicinal cannabis
• Worldwide consumer cannabis spending expected to accelerate to nearly $17 billion at a CAGR of 38 percent in 2019, reaching $31.3 billion in 2022

Canadian cannabis product manufacturer The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF) is riding a bright green wave as the cannabis industry continues to make history in Canada and throughout the world. The cannabis industry had much to cheer about in 2018, as Canada became the first industrialized country in the world to greenlight recreational cannabis for adult use and the United States legalized hemp and hemp-based cannabidiol products by signing the Farm Bill into law. Global sales of cannabis are expected to grow 38 percent in 2019 to nearly $17 billion, with sales projected to surpass $31 billion by 2022, according to Arcview Market Research (http://ibn.fm/qlmJ6).

The Flowr Corporation joined in that global celebration with its own good news after receiving approval from Health Canada to open additional grow rooms at the company’s Kelowna 1 cultivation facility. The additions will raise the total number of premium cannabis flower rooms to 10, which are expected to more than double current capacity, according to a company news release (http://ibn.fm/kWAGX). Kelowna 1 is Flowr’s initial cultivation facility, which is under construction in the world-famous Okanagan Valley of British Columbia. Flowr expects to have the facility complete with a total of 20 grow rooms prior to the end of the third quarter of this year. When complete, Flowr expects the approximately 85,000 square foot facility to produce at a capacity of approximately 10,000 kilograms of premium cannabis flower on an annualized basis.

The buildout is strategically planned to accommodate the growing demand for Flowr’s products from its provincial partners and to meet its new medical cannabis supply agreement with Shoppers Drug Mart, as noted in a news release by Tom Flow, co-CEO of Flowr Corporation. Shoppers Drug Mart is Canada’s largest retail pharmacy chain, with 1,300 locations from coast to coast (http://ibn.fm/N6n2f).

“The shortage of premium adult-use cannabis we predicted has become a reality since last October and ramping up our facilities will provide much-needed, high-quality product to the market,” Flow stated in the news release.

Shortages in the Canadian cannabis supply line became apparent almost immediately after recreational adult-use sales become legal in October 2018, with some stores opening on a limited basis and provincial sales licenses placed on hold or restricted for a time as supply and demand forces worked to catch up to each other (http://ibn.fm/m2269). Recently released Health Canada cannabis inventory and sales data reveal a complicated shortage versus rebound supply problem as producers, government regulators and consumers try to settle on a workable solution (http://ibn.fm/AJkYv).

Supply and demand may be an even more difficult balancing act when it comes to premium, high-quality cannabis products, which many cannabis users tell market researchers they prefer. According to Deloitte’s 2018 cannabis report, a majority of current cannabis users expect to pay more and are willing to pay a premium for products that are grown and processed under Canada’s new regulatory guidelines and sold through legal channels (http://ibn.fm/GeuUQ).

Flowr Corporation is once again proving to be an industry leader, as the company recently announced the hiring of Deron Caplan, North America’s first PhD whose research focused on cannabis production. Caplan joins Flowr as director of plant science, a role that will prove symbiotic to each as the company grows its brand and continues to emphasize the wisdom of generating premium, non-irradiated cannabis at high yields.

Caplan earned his doctorate at the University of Guelph in August 2018 and was the primary author of the first peer-reviewed paper on indoor cannabis production published in North America. He has written numerous articles on cannabis published in scientific journals, is a sought-after cannabis expert by media outlets and has testified on cannabis production before the Canadian Senate’s Standing Committee on Agriculture and Forestry (http://ibn.fm/j0Pnc). Caplan is an expert on growing substrates, fertilization protocols, propagation techniques and irrigation management protocols for cannabis production under a controlled environment. While earning his doctorate, he, along with his academic advisors, invented four growing substrates specifically formulated and tested for cannabis production.

“Flowr is focused on producing premium quality cannabis at scale with industry-leading efficiency and that requires remaining a leader in both cultivation techniques and genetics,” Flow said in announcing Caplan’s new role at Flowr Corporation. “We believe that adding Deron to our existing team and alliance with Hawthorne Canada strengthens our position at the forefront of understanding the tools and techniques needed to grow great cannabis.”

This commitment to producing a premium, ultra-high-grade cannabis product led to a research and development partnership with Scotts Miracle-Gro (NYSE: SMG) subsidiary Hawthorne Gardening. In October 2018, the two companies broke ground on North America’s first research and development facility dedicated to advancing cannabis cultivation techniques (http://ibn.fm/QQLFk).

For more information, visit the company’s website at www.Flowr.ca

• Sharing Services is pioneering its own unique brand of home-based entrepreneurial success in the direct sales industry under the Elepreneur banner
• The company reported record revenues at the end of October 2018, while expanding the company and reporting sales of more than $39 million during the year since its products launched
• As Sharing Services’ global reach continues to expand in 2019, it is introducing a new chief marketing officer who’s experienced in international business

Sharing Services Inc. (OTCQB: SHRV) is building on the successes of a blockbuster year as it looks ahead to 2019’s blue horizons for the entrepreneurship that keeps global commerce vibrant.

The diversified holdings company and the energetic “Elepreneurs” who are elevating the realm of home-based business gathered in revenues of more than $39 million during the first year since the December 2017 launch of the company’s products under its subsidiaries. Sharing Services’ direct-selling protocol is delivering a growing selection of health and wellness products to the world with a focus on promoting the well-being of all people, as well as insurance coverage for auto, home, health and life concerns and health benefit discounts to families that share the company’s goal of elevating life.

Sharing Services is also invested in soon delivering wholesale travel and payment programs that empower families to go on vacation, along with live seminars and training events to “elevate the skills and knowledge of entrepreneurs around the world.”

“Since our launch into the marketplace almost a year ago, product sales for our incredible health and wellness division of Elevacity Global have dramatically increased and continue to grow,” CEO John “JT” Thatch stated in December in announcing record revenues of $17.9 million for the company’s fiscal second quarter. “Our second-quarter results represent yet another significant milestone as we exceed our goals at a record-breaking pace and execute our mission to change the direct-selling industry with best-in-class products and services under our unique ‘Blue Ocean Strategy.’”

Blue Ocean Strategy and its Red Ocean corollary are marketing theory terms that address self-directed companies’ efforts to create their own market spaces where they can capture and control revenues in “blue oceans” that are free of the competition bloodying the “red oceans” of more defined industries and their market parameters (http://ibn.fm/efGIU).

Sharing Services’ strategy involves creating its own market universe by melding key components of its subsidiaries. To bolster its direct sales mission, the company held its first “Elepreneur Happiness Convention” last year, with its sales representatives gathered from around the world, including the United States, Canada, Mexico, Singapore and Hong Kong, to network and elevate their capacity for success.

As part of its effort to elevate its successes on a corporate level for the coming year, Sharing Services announced on January 9 that it has named Clare Holbrook, a direct sales industry veteran, to the role of chief marketing officer for its Elepreneur, LLC subsidiary (http://ibn.fm/K5cB4). The decision reflects Sharing Services’ expanding international reach; Holbrook is an “international polyglot” who is able to communicate effectively in five languages and has worked and lived throughout the United States, United Kingdom and the European Union, fulfilling responsibilities on four continents in more than 20 countries.

“Since its launch in December 2017, Elepreneur has quickly established itself in the direct-selling industry and continues to elevate the home-based entrepreneur experience. We continue to grow at a rapid pace, and we are pleased to have Mrs. Holbrook’s experience in marketing and branding the company’s future growth,” Thatch stated in a news release.

For more information, visit the company’s website at www.SHRVInc.com

• License revocation and production cuts involving world’s largest iron ore producer have already contributed to upward price trends in the iron ore market
• Existing shortage in pellet production feed expected to worsen as a result of recent events in Brazil
• These latest market developments are creating positive conditions and opportunities for industry representatives like Black Iron that already benefit from strategic advantages

The world is anticipating an annual iron ore production loss of 70 million metric tons after Brazilian state regulators revoked the license for the second-largest iron ore mine owned by Vale (NYSE: VALE) – the world’s largest iron ore miner – on February 5, Bloomberg reported (http://ibn.fm/qnD6o). The 30 million metric tons of production lost at this mine are in addition to Vale’s earlier announcement that it is taking 10 of its mines with upstream tailings dams out of production, representing 40 million metric tons of production. The license revocation is providing strong indications that company operations are not going to return to normal in the near future. Vale SA came under strict government scrutiny after a fatal accident caused the death of over 150 people and halted mining operations on January 25, 2019.

As a result of the license revocation and suspension of operations, Vale declared force majeure on some of its contracts.

Analysts are already noticing market dynamics resulting from the announced cuts and the revocation of Vale’s mining license. The benchmark price of 62 percent iron content ore went up more than $15 per metric ton since January 25 to the current $90 per metric ton. Iron ore mining companies noted a corresponding significant increase in share prices, with Ukraine-based Ferrexpo up 32 percent, Australia’s Fortescue Metals up 27 percent and Canada’s Champion Iron up 37 percent, while Vale’s share prices have dropped about 24 percent since January 24, a day before the accident.

The latest market dynamics will undoubtedly impact industry representatives like Black Iron Inc. (TSX: BKI) (OTC: BKIRF) (GR: BIN). Black Iron is a Canadian iron ore exploration and development company that’s working on advancing production at its wholly owned Shymanivske Iron Ore Project. The site is located in central Ukraine and is surrounded by five operating iron ore mines owned by majors including ArcelorMittal and Metinvest.

The Shymanivske project holds a mining allotment permit for a large iron ore deposit. It is estimated to contain approximately 646 million tons (Mt) measured and indicated mineral resources that consist of 355Mt measured mineral resource grading 31.6 percent total iron and 18.8 percent magnetic iron. There’s also a 290Mt indicated mineral resource grading 31.1 percent total iron and 17.9 percent magnetic iron. Finally, the project features 188Mt of inferred mineral resource grading 30.1 percent total iron and 18.4 percent magnetic iron.

This highly developed mining region already features all of the costly major infrastructure required to advance iron ore mining projects. There is a rail line with confirmed surplus capacity within one mile, electrical power tie-in only 20 miles away and several sea ports located 150 to 260 miles from the mine site. In addition, the district is known for the highly skilled labor force coming from the city of Kryvyi Rih, with its population of 650,000 people located only six miles from site.

At its Shymanivske Iron Ore Project, Black Iron aims to produce high grade 68 percent iron ore concentrate with few impurities at a very low cost, which it expects to sell for a premium price once in production.

Iron ore concentrate is one of the key resources required by the steel industry. Black Iron’s concentrate can be used both in sinter and highly valued pellet production. Prior to the latest Brazilian development, there was already a shortage of pellet feed. The supply/demand gap is set at 133Mt against the current base of approximately 400Mt consumed by 2035. According to Zion Market Research, the global iron ore pellet market was valued at $25.22 billion in 2017 and is expected to reach $50.12 billion by 2024 (http://ibn.fm/u3Fkn).

Black Iron is working on advancing its project on several fronts, including off-take agreements and construction funding. In addition, Back Iron is negotiating with Ukraine’s Ministry of Defense on the transfer of a land parcel required for the company’s processing plant. The project has already attracted the interest of multiple steel mills and international traders willing to make a significant equity investment in return for long-term purchase contracts.

The technical and scientific contents of this article have been reviewed and approved by Matt Simpson, P.Eng., CEO of Black Iron, who is a Qualified Person as defined by NI 43-101.

For more information, visit the company’s website at www.BlackIron.com

• The Green Organic Dutchman is a producer of first-rate organic cannabis
• The company recently provided a construction update on its Valleyfield and Hamilton operations
• TGOD and the Greek government have had discussions concerning the nature of proposed operational plans in the country

Established in 2012, The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) focuses on the production of premium certified organic cannabis. The company’s organic process includes living soil, sustainable energy and laboratory certification and testing. Its organic processes are certified by Ecocert, one of the most astute organic certification organizations. The company’s operational emphasis is on medical cannabis markets in Canada, Europe, the Caribbean and Latin America, as well as the Canadian adult-use market. Headquartered in Mississauga, Ontario, The Green Organic Dutchman is working on becoming the largest organic cannabis enterprise in the world.

TGOD is one of the lowest cost, highest quality producers in Canada and has one of the most diverse, experienced and proven management teams in Canada (http://ibn.fm/ZZX7E). The company produces farm grown, high quality organic medical cannabis in small batches. It does so employing organic craft growing principles. Its organic products are free from pesticides, herbicides and synthetic nutrients. Fundamentally, TGOD’s processes produce 100 percent non-irradiated premier organic cannabis grown in living soil.

Recently, TGOD provided a comprehensive construction update on its domestic Valleyfield, Quebec, and Hamilton, Ontario, operations. Major progress has been made toward the completion of both facilities. In January 2018, construction started on the 2,700 sq. ft. breeding facility in Valleyfield. In April 2018, the facility was completed. Moreover, in June 2018, it received a cultivation license (http://ibn.fm/jF5zC).

The engineering design improvements optimize facility throughput. This, in tandem with organic specific modifications, provides a forecast domestic productive capacity boost from 156,000 kg to 202,500 kg.

Regarding the Hamilton operations, TGOD has modified major systems from the original design. Furthermore, the company has re-engineered the whole harvesting process to enhance production uptime and facility throughput. Therefore, this has resulted in increased productive capacity from 14,000 kg to 17,500 kg. TGOD has grown and successfully harvested numerous crops in the pilot facility. It has also stored product for its forthcoming medical pilot launch.

In a news release, Brian Athaide, TGOD’s chief executive officer, said, “Not only have we addressed the important redesign requirements, we have also made significant improvements to the operating capacity and capital timing of our facilities, resulting in an additional 46,500 kgs of productive capacity.”

In addition, TGOD recently commented on the Greek Ministry of Agriculture’s press release and CNN’s (Greece) coverage (dated January 25, 2019) related to TGOD’s proposed Greece operations (http://ibn.fm/zNtfS). TGOD and the Greek government have had advanced talks regarding the nature of the proposed plans. Since early 2018, TGOD has been in communication with different Greek Ministries, including the Ministry of Rural Development and Food. The company is waiting on a license for the production of medicinal cannabis. TGOD has confirmed plans to build and commission a multi-phased facility, subject to licensing from the Greek government.

With a funded capacity of 219,000 kg, TGOD offers a compelling opportunity for perceptive investors. TGOD is constructing 1.64 million sq. ft. of facilities across Ontario, Quebec, Denmark and Jamaica. The company, with its global initiatives, is at the frontline of production of premium certified organic cannabis.

For more information, visit the company’s website at www.TGOD.ca

• John “JT” Thatch, CEO, explains expansion of SHRV in 2019 into Canada and Asia in interview at LD Micro Main Event with www.ProactiveInvestors.com, as seen on YouTube
• SHRV said that the name change will reflect its international growth strategy; in SEC filing, it says it plans for organic growth, expansion through acquisition and opportunities in other countries
• In interview, Thatch estimated that the company is on track to record sales of $50 million in 2018

Sharing Services Inc. (OTCQB: SHRV) will hold a special meeting of shareholders on January 11 for a vote to change its name to Sharing Services Global Corporation (http://ibn.fm/fln8E). John “JT” Thatch, CEO of SHRV, said that the name change would more accurately reflect the company’s international expansion moves in 2019. He discussed the company’s strategic growth into Canada and Asia in an interview with www.ProactiveInvestors.com, as seen on YouTube (http://ibn.fm/fc37I).

SHRV is a Plano, Texas-based diversified holdings company that owns, operates or controls a variety of companies engaged in direct selling through independent sales representatives. It also offers services in the energy, technology and insurance sectors. Its divisions include Elevacity Global, LLC and Elepreneur, LLC.

In its filing, the company noted that it was planning to grow both organically and by making strategic acquisitions of businesses and technologies. “The company believes there are excellent growth opportunities outside the United States, including in Canada, Mexico, Europe and Asia,” it said in the filing.

Thatch also said in the interview at the LD Micro Main Event that SHRV would report revenues of some $50 million for 2018. It had earlier recorded sales of $17.9 million for its fiscal Q2 2018 and $12.9 million revenue for Q1 2018 (http://ibn.fm/YDKEz).

For more information, visit the company’s website at www.SHRVInc.com

• Multiple breakthroughs in the field of onco-immunology are expected over the next 20 years
• BriaCell Therapeutics Corp. is a frontrunner in this area, as it has already established proof of concept for its Bria-IMT solution for advanced breast cancer patients
• The company is also developing Bria-OTS, a personalized off-the-shelf solution, that will be much easier and less costly to manufacture than comparable personalized immunotherapies

According to a report published in the British Society of Immunology, a new era has begun in the battle against cancer, as the development of immunotherapies for malignancies will take cancer treatments to a whole new level (http://ibn.fm/FRJZN). Several companies, including BriaCell Therapeutics Corp. (OTCQB: BCTXF) (TSX.V: BCT), are leading the way.

The British Society of Immunology article, part of a wider report marking 60 years of immunology, takes a brief look at the history of immunotherapies used to treat cancer, as well as the biggest limitations and expectations for the future. According to the report, this next era of cancer treatment had a major turning point with the development of monoclonal antibodies, followed by attempts to redesign T-cells, one of the body’s most important cancer fighting units. Many efforts now are directed toward the preventative aspects of immunotherapies in hope of developing a vaccine-based cure for cancer by 2020.

According to Frontiers of Immunology, a stream of breakthroughs will be observed in the field over the next 20 years (http://ibn.fm/eEbww). Immunotherapeutic approaches will be enhanced and selectively combined to help the immune system target malignancies without causing needless toxicities.

The global cancer immunotherapy market currently holds approximately 50 percent of the entire oncology therapeutics market. It generated $54 billion in 2016 and is expected to reach more than $100 billion by 2022 (http://ibn.fm/bPdce).

By 2026, immunotherapy solutions are anticipated to become the treatment of choice for various types of cancer. Estimates suggest that approximately 60 percent of previously-treated cancer patients will likely adopt an immunotherapeutic approach within this timeframe.

BriaCell Therapeutics Corp. is a Berkeley-based clinical-stage biotechnology company that’s currently focused on the development of targeted immunotherapy solutions for advanced breast cancer patients. Its primary candidate, Bria-IMT, has demonstrated excellent results in several clinical trials to date.

Bria-IMT works by providing breast cancer antigens. In addition, the treatment directly stimulates the T-cells to maximize their anti-cancer capabilities. Bria-IMT has already achieved proof of concept in clinical trials, with its safety and tolerability assessed as excellent. The effectiveness of the immunotherapy is high, as it managed to elicit tumor regression even in the case of heavily pre-treated advanced breast cancer patients.

The latest research outcomes have resulted from a combined study of Bria-IMT and KEYTRUDA (pembrolizumab) by Merck & Co. Inc. (NYSE: MRK). The combination was well tolerated in all six patients participating in the trial. This clinical trial is ongoing, and additional information about the outcomes will be provided in the first quarter of 2019, according to BriaCell Therapeutics Corp.

Apart from subjecting Bria-IMT to strenuous clinical trials, BriaCell Therapeutics Corp. is also working on the development of Bria-OTS – a personalized off-the-shelf immunotherapy solution for advanced breast cancer patients. Bria-OTS will be the first personalized immunotherapeutic solution to offer cost-effectiveness and an easier manufacturing process when compared to existing therapies.

Upon its development, Bria-OTS is expected to cover over 99 percent of the patient population. It is expected to deliver an immune response against the specific cancer tailored to each patient without necessitating a complex manufacturing and logistics process.

For more information, visit the company’s website at www.BriaCell.com

• Big corporations are investing in the cannabis industry
• Major tobacco company provides financing for LXRP
• LXRP boasts revenue streams within the nicotine industry and opportunity in other sectors
• Lexaria is a unique company doing business on its own terms

The cannabis industry is experiencing impressive growth thanks to both legal and social changes worldwide, and big corporations are stepping up to invest. In a new Audio Press Release (“APR”), CannabisNewsAudio praised Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) (http://ibn.fm/sR2IL) for building a large funding deal on its own terms. The APR, ‘Outside Investment, New Technology Support Growing Cannabis Industry’, highlighted Lexaria’s ability to create subsidiaries specializing in the use of DehydraTECH.

Through the deal, Lexaria Nicotine LLC, a wholly owned subsidiary of Lexaria, has received an initial investment in the amount of $1 million – with the option for funding to increase to up to $12 million – from one of the world’s largest tobacco companies; the capital has been earmarked for research and development (http://ibn.fm/ChHLT). Lexaria will maintain its independence, while the investing company receives only minority ownership of the subsidiary. This unique arrangement allows the tobacco company to buy into LXRP without Lexaria actually selling any of its parent company.

Lexaria is strategically positioned to benefit from new revenue streams based on this deal. The company will receive royalties on any nicotine products created with DehydraTECH and be able to showcase its unique technology to other industries.

In addition to Lexaria Nicotine, LXRP has three more wholly owned subsidiaries that are working in various industries to create new deals on Lexaria’s terms.

• Lexaria CanPharm Corp. focuses on providing DehydraTECH to the global cannabis industry
• Lexaria Hemp Corp. focuses on providing DehydraTECH to the hemp-based food and supplements industry
• Lexaria Pharmaceutical Corp. focuses on licensing DehydraTECH to the pharmaceutical sectors

DehydraTECH is a drug-delivery platform patented for cannabidiol and all other non-psychoactive cannabinoids, as well as THC (tetrahydrocannabinol) and psychoactive cannabinoids. The technology is an enabling platform that works across multiple industries, thereby providing a large base of consumers with healthier forms of consumption than lighting up.

LXRP and DehydraTECH stand out among the competition. The company has a total of 10 patents issued with more than 50 patents pending worldwide. Few companies within the cannabis industry have attracted the attention of Fortune 500-type corporations, and even fewer are inking deals on their own terms. Lexaria Bioscience is one such stand-out.

For more information, visit the company’s website at www.LexariaBioscience.com

• Effective February 4, Supreme Cannabis securities began trading on the Toronto Stock Exchange
• Supreme is focusing on pursuing opportunities in the emerging global cannabis market and generating sustainable growth
• Supreme’s wholly owned subsidiary, 7ACRES, cultivates craft-quality cannabis on a commercial scale

The Supreme Cannabis Company Inc. (TSX: FIRE) (OTC: SPRWF) (FRA: 53S1) has started trading on the Toronto Stock Exchange (“TSX”). Effective February 4, the company’s listed securities began trading under ticker symbols ‘FIRE’ and ‘FIRE.DB’ (http://ibn.fm/ENb2b).

This move is designed to support the company’s strategy of targeting premium brands, leverage its coast-to-coast distribution in Canada and aid in its expansion into the international cannabis market. The company will also focus on generating sustainable growth. The company’s common shares and senior unsecured convertible debentures due in 2021 were voluntarily delisted from the TSX Venture Exchange when trading began on the TSX.

The move to the TSX comes as the company’s future looks especially promising. Supreme estimates that its annual production target will grow early this year to full capacity, from its current 17,500-50,000 kg. (http://ibn.fm/i8OMC). The company is focused on penetrating the global cannabis market. Supreme sees its marketing effort in Canada – where it has achieved national wholesale distribution, operated retail stores and offers online availability – as especially appealing to legal-aged cannabis enthusiasts (“LACE”).

The Toronto-based company plans to grow in what it sees as an emerging global market and seeks to expand by satisfying the needs of LACE consumers for premium cannabis. Supreme is focused on producing quality product that commands higher price points than competitors. The company is deploying a timing strategy of “first in, wins,” when it comes to national listing success.

Supreme’s wholly owned subsidiary, 7ACRES, operates a 440,000-square-foot facility in Ontario, where it cultivates craft-quality cannabis on a commercial scale. The one-of-a-kind hybrid greenhouse uses advanced HVAC and CO2 enrichment, combining the best practices of indoor cannabis cultivation with the power of the sun.

In addition, Supreme has a long-term global distribution partnership agreement with Lesotho-based Medigrow for the export of medical-grade cannabis oil to Canada and other international markets.

For more information, visit the company’s website at www.Supreme.ca

• Targeted global markets include $1.43 billion nematicide industry, $9.5 billion biopesticide industry
• Economic impact of crop damage caused by soil-borne nematodes estimated at $100 billion worldwide
• The EPA has banned most synthetic fumigant nematicides and is also restricting the use of non-fumigant nematicides
• Consumer demand for organic products has increased the need for sustainable, green solutions
• Currently finalizing development of AITC liquid concentrate for drip line delivery platform
• Testing underway for potential application as a natural pre-plant soil treatment in the cannabis industry
• Based on third-party studies, MustGrow’s technologies deliver superior pest and pathogen control compared to harmful synthetic chemicals that are being banned

MustGrow Biologics Corp. is an agricultural biotech company focused on developing and commercializing its patented technology that is a natural biopesticide and biofertilizer for use as a fertilizer, nematicide, pesticide and fungicide. MustGrow’s novel and proprietary solutions utilize organic components refined from mustard seed to provide high quality, organic pest control to growers facing challenges associated with soil-borne diseases and pests such as nematodes. The company’s technology provides an all-natural, effective, safe and easy-to-use solution for farmers seeking to raise healthy crops without the use of pesticides.

Nematodes, or microscopic worms, are the most numerous multicellular animals on earth. A handful of soil will contain thousands of nematodes, many of which are parasites of insects, plants or animals. Most plant-parasitic nematodes feed on the roots of plants, damaging the root system and reducing the plant’s ability to absorb water and nutrients (http://ibn.fm/0AnvA). For the past 50 years, nematodes have been controlled using chemical nematicides, but the Environmental Protection Agency now restricts or bans many of the chemical formulations.

MustGrow’s technologies provide nematode control that is equal and often superior to synthetic alternatives, resulting in elevated yields and increased returns for the grower. The global economic impact of soil-borne nematodes is estimated at nearly $100 billion in lost crops per year. The American Phytopathological Society (http://ibn.fm/SlUtJ), an international nonprofit scientific organization dedicated to the study and control of plant diseases, estimates that plant-pathogenic nematodes are responsible for 14 percent of crop losses worldwide.

MustGrow’s technology refines mustard seeds to concentrate the plant’s natural organic compounds that form Allyl isothiocyanate (“AITC”), which serves the plant as a natural defense system against pests and diseases. As a result, MustGrow’s novel product offers first-class performance, is 100 percent natural, and its fertilizer product is listed for organic use by the Organic Materials Review Institute (“OMRI”) under specifications set by the USDA’s National Organic Program.

MustGrow’s initial technology was a granular pre-plant soil biofumigant and biofertilizer containing the active ingredient AITC, a proven nematicide, fungicide and fertilizer. The company has completed 110 independent third-party field trials on fruit and vegetable crops. As a biofertilizer, MustGrow’s product is registered with Health Canada and the EPA in all U.S. states as OMRI-certified. It is also registered for use as a biopesticide by the EPA in key fruit and vegetable growing U.S. states (except California) and with Health Canada. MustGrow is finalizing a new liquid delivery platform with increased concentration of the same active ingredient (AITC) that can be applied through drip lines to meet the demands of today’s growers.

Results of tests completed to date show that MustGrow continues to provide innovative solutions with broad based applications within agriculture. Validated field trial results include:

• 100 percent control of root-knot nematodes in strawberry crops as compared to methyl bromide
• 55 percent tomato crop yield increase
• 95 percent control of Pythium root rot in lettuce fields
• 70 percent reduction in Verticillium root severity in cucumbers
• Market Opportunity

Market Opportunity  

MustGrow is also testing the potential application of its technology to the cannabis industry, which is projected to grow to nearly $22 billion in the U.S. by 2020. While there are no uniform guidelines for pesticide use in the cannabis industry, state-by-state regulations in the U.S. do exist which has led to instances of pesticide-tainted cannabis showing up in tested products, leading to recalls and threats of lawsuits. Health Canada recently published regulations for mandatory testing for pesticides in cannabis that are now in effect for all growers. MustGrow’s potential application for cannabis production shows that when its product is used as a pre-plant/pot soil treatment, it may significantly help control many soil-borne diseases, pathogens and pests, including nematodes, fusarium, rhizoctonia, and botrytis (gray mold) that affect the cannabis plant. Cannabis consumers are increasingly demanding organic products free from chemicals and have shown they are willing to pay a premium for high-quality organic cannabis. MustGrow is currently running cannabis soil trials and is seeking Health Canada approval for use of its product on cannabis.

Global crop protection is a multibillion-dollar market that is expected to surge over the next five years. Sales of nematicides are set to grow by 33 percent to $1.43 billion by 2022, while biopesticides are projected to leap by 94 percent to an estimated $9.5 billion by 2022. MustGrow is targeting the global nematicide industry with products that include an innovative pre-plant soil treatment. Solutions for the global biopesticide industry include seed treatment technologies, fungicides and nematicides.

MustGrow’s groundbreaking technologies use novel plant compounds to provide superior crop protection naturally.

Management Team

President and CEO Corey Giasson is an entrepreneur with more than 20 years in the agriculture, potash, oil and gas, mining and real estate industries. Mr. Giasson co-founded Rallyemont Energy Inc., a heavy oil company that successfully identified 140 million barrels of recoverable heavy oil, that was sold in 2013 to Husky Energy. He holds an MBA and bachelor’s degree in agricultural economics from the University of Saskatchewan.

Chairman Brad Munro has 20-plus years as a vice president/investments, with a national venture capital firm where he sourced, invested and managed the activity of over 30 companies and invested $150 million. He has served as a director of over 20 public companies and a greater number of private enterprises. Munro is currently director of Secure Energy Services.

COO Colin Betsky is the previous vice president/BioAg at Novozymes, where he was responsible for the company’s BioAg business worldwide. He holds a bachelor’s degree in agriculture from the University of Saskatchewan and has more than 20 years of experience in agricultural chemicals and biologics.

Director Tom Flow is the founder and current president of The Flowr Corporation (TSX.V: FLWR) and Licensed Producer of cannabis in Canada. He founded and built MedReleaf, Canada’s most profitable Licensed Producer which was later acquired by Aurora Cannabis (TSX: ACB) (NYSE: ACB) for $3.2 billion. Flow is widely recognized for his leadership and expertise in building and operating cannabis cultivation facilities.

Director Matt Kowalski has a tremendous amount of experience in the fruit and vegetable and biologics industries. Under his leadership at Natural Industries, a business focused on biological pest control, the company was awarded five EPA registrations: three biofungicides, a bionematicide, and a bioinsecticide. In November 2012, Kowalski led the strategic sale of Natural Industries to Novozymes BioAg. He is the principal owner of Stronghold Keep Inc., an investment corporation.

CFO Todd Lahti has extensive experience evaluating and managing start-up companies in the biotechnology, agricultural and oil and gas sectors, working directly on financing transactions, mergers and acquisitions, corporate strategy, business development, technology transfer and operations set up. He is a Chartered Financial Analyst and a Chartered Professional Accountant.

For more information, visit the company’s website at www.MustGrow.ca

• The e-commerce platform will incorporate Pacific Software’s Agri-Blockchain technology, as well as IoT solutions to increase transparency and safety
• In its annual letter to shareholders, Pacific Software outlined a number of additional financial and company development goals accomplished throughout 2018
• Based on its rapid growth, the company expects to maintain the speed of development through 2019 and to implement a business plan focused on further expansion

Business development technology innovator Pacific Software Inc. (OTC: PFSF) anticipates the launch of its cross-border Brazil-China ecommerce trade platform in Q1 2019, as the company announced in a recently-issued shareholder letter (http://ibn.fm/0At7w). The letter outlines the company’s biggest accomplishments and milestones in 2018. It also sheds some light on future goals and anticipated developments for 2019.

The e-commerce platform is currently in the process of being developed. It will be a digital, blockchain-supported e-commerce website that will link Brazilian agricultural suppliers to China. Pacific Software’s Agri-Blockchain technology will be incorporated to increase the transparency of transactions and guarantee trust in the origin, quality and safety of products.

Additionally, Pacific Software is working toward the integration of Internet of Things (“IoT”) solutions with the platform. Such capabilities are expected to enable the extraction of data derived from Internet-connected devices like barcode readers. This way, the e-commerce platform will accumulate valuable product data to ensure effective supply chain management.

The annual shareholder letter also highlighted the key Pacific Software milestones of 2018. During the year, the company opened an office in Hong Kong and incorporated HyperSoft Ventures as a wholly owned subsidiary. The subsidiary may host the B2B cross border e-commerce platform and procure clients as an application service provider.

An audited financial statement was completed in 2018, as the company’s also considering an uplisting to the OTCQB Venture Market or other stock trading platforms. The company’s revenue model has manifested in the form of a monthly subscriber fee for basic functionality, higher fees for premium functionality, variable fees for marketing tools, revenue sharing with platform partners and transaction fees for collective product orders.

As far as 2018 accomplishments go, Pacific Software also announced that it has completed the development of e-commerce platform solutions and features for the company’s subscribers. Some of these features include smart contracts, digital marketing, customs levies, search/match applications, blockchain solutions, advertising and more.

The shareholder letter concluded with a brief statement outlining plans for 2019 and beyond, underlining Pacific Software’s commitment to work hard as to maintain the rapid pace of development from 2018. The business plan provides for further expansion into the commercial markets of Brazil and China with product, business and staffing development.

Pacific Software is an emerging development technology corporation that focuses on investments, mergers and acquisitions of software-based technological solutions and platforms. The company boasts a major strength in terms of B2B and B2C e-commerce blockchain solutions development – its utilization of the IBM Hyperledger Blockchain Backend as a Service (“BaaS”) infrastructure. The Pacific Software trade platforms is expected to improve product traceability and digitize the trade process.

For more information, visit the company’s website at www.PacificSoftwareInc.com